CLAIM #33883 · Johnson & Johnson (JNJ) · 2024Q2 earnings call · Jul 17, 2024 · due Mar 31, 2025
“Especially between now and the time that we bring our PFA technology to market, we're confident. While we don't control the timing, we expect to have that by the end of the year or early next year.”
Timothy Schmid · Executive VP, MedTech
PENDING
graded after results covering Mar 31, 2025 are reported
Verify independently
SEC filings for JNJ ↗ · Claim quote is verbatim from the 2024Q2 earnings call.